In a transaction on April 13, 2022, major shareholder Braden Michael Leonard acquired further shares of Gemini Therapeutics Inc. (GMTX). Disclosed in an SEC filing
Gemini Therapeutics Inc. (GMTX) shares collapsed 35.01% in after-hours on Tuesday, June 22, 2021, and closed the day at $6.35 per share. Earlier in the
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.